Xact Kapitalforvaltning
ETF · SE0011452127 · DKK
202.80DKK
−0.6%last day
Price as of 2 October 2026
Performance
1 month
−5.3%
1 year
+13.9%
3 years, per year
+4.9%
5 years, per year
+0.9%
Largest fall, 3 years
−28.8%
Below the peak now
−5.9%
Volatility, 1 year
15.7%
Return with dividends reinvested.
Quality, value and trend
The trend is the price development over the past year measured against other funds and ETFs. 100 is best.
60
Profitability and a sound balance sheet over time. Better than 60% of Nordic stocks.
43
The price measured against earnings, assets and cash flow. Better than 43% of Nordic stocks.
24
The price development over the past year. Better than 24% of funds and ETFs.
The fund's largest holdings
| Novo Nordisk A/S | 14.1% |
| DSV A/S | 12.1% |
| Danske Bank A/S | 11.1% |
| Vestas Wind Systems A/S | 10.3% |
| Novonesis (Novozymes) A/S | 7.8% |
| Genmab A/S | 6.3% |
| Orsted A/S | 3.5% |
| Coloplast A/S | 3.4% |
| A.P. Møller - Mærsk A/S | 3.2% |
As of 2 October 2026, source eodhd_top10.
About the fund
Xact Kapitalforvaltning is an exchange-traded fund (ETF) traded in DKK.
See the full analysis in InvestWiser.
The charts, holdings and the comparison with other funds are in the app.
See the full analysis